Personalised medicine: patient groups call on regulators to set approval route A new campaign seeks to persuade regulators to set new rules for approving personalised treatments that are currently in clinical development. 07 Oct 2009 News
Publicly funded cancer research ‘too focused on early-stage drug development’ Cancer research is not pursuing advances in knowledge likely to have the biggest impact on combating the disease in the next few decades, conference hears. 23 Sep 2009 News